Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Adrianne Mallen"'
Autor:
Michelle L Kuznicki, Adrianne Mallen, Kristal Ha, Emily Clair McClung, Antonio V Castaneda, Biwei Cao, Brooke L Fridley, Hye Sook Chon, Jing Yi Chern, Mitchel Hoffman, Robert M Wenham, Koji Matsuo, Mian M K Shahzad
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0268794 (2022)
ObjectivesCentral nervous system metastases (CNSm) secondary to endometrial cancer (EC) are rare. As a result, prognostic factors for this patient population are not well described.MethodsEC patients with CNSm were identified retrospectively from two
Externí odkaz:
https://doaj.org/article/85c8f829b691420b8b9d6762abcde831
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss , Pp 100754- (2021)
Stage IIIC is the most common stage of locally advanced sub-stage of endometrial cancer, nevertheless, the optimal management for these patients remains controversial. Adjuvant chemotherapy alone more effectively suppressed distant metastases but res
Externí odkaz:
https://doaj.org/article/4ce00757bcef4ffe83de019d047c377b
Publikováno v:
Journal of Gynecologic Surgery. 36:267-271
Objective: The purpose of this study is to present a case series of surgeries performed for patients with distorted cervical anatomy and suspected cervical and/or endometrial pathology. Currently, ...
Autor:
Ali Wells, Michelle Kuznicki, Bernadette M. Boac, Adrianne Mallen, Shelley S. Tworoger, Susan T. Vadaparampil, McKenzie McIntyre, Brooke L. Fridley, Robert M. Wenham, Mary K. Townsend, Sarah Todd, Bianca Augusto, Anjalika Gandhi, Claire C. Conley
Publikováno v:
Clin Genet
Germline mutations (e.g., BRCA1/2) have prognostic and treatment implications for ovarian cancer (OVCA) patients. Thus, national guidelines recommend genetic testing for OVCA patients. The present study examines patterns and predictors of genetics re
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss, Pp 100754-(2021)
Gynecologic Oncology Reports
Gynecologic Oncology Reports
Highlights • Stage IIIC endometrial cancer (EC) treatment remains controversial. • Radiation therapy improves local control but does not confer survival benefit. • Chemotherapy can improve overall survival. • Advances should result from perso
Publikováno v:
Gynecologic Oncology Reports
Highlights •
Autor:
Jing-Yi Chern, Biwei Cao, Matthew L. Anderson, Brooke L. Fridley, Susan T. Vadaparampil, Kathryn Cline, Adrianne Mallen, Susan H. Read
Publikováno v:
Gynecologic Oncology. 162:S231-S232
Objectives: Genetic profiling is rapidly emerging as standard of care for women diagnosed with uterine cancer. Optimal strategies for ensuring that genetic profiling is performed in a timely manner and that uterine cancer patients understand genetic
Autor:
Marina Sehovic, Hye Sook Chon, Martine Extermann, Adrianne Mallen, Sarah L. Todd, Sharon E. Robertson, Jongphil Kim, Robert M. Wenham
Publikováno v:
Gynecologic oncology. 161(3)
Older women have a worse prognosis with advanced epithelial ovarian cancer (EOC) and comorbidities likely contribute to poor outcomes. We sought to identify comorbid conditions and treatment-related factors in older women.A retrospective chart review
Autor:
McKenzie McIntyre, Dana Ketcher, Brooke L. Fridley, Robert M. Wenham, Susan T. Vadaparampil, Mary K. Townsend, Adrianne Mallen, Bianca Augusto, Shelley S. Tworoger, Lindsay Fuzzell, Claire C. Conley, Laura V. Barton
Publikováno v:
Support Care Cancer
OBJECTIVE: Identify predisposing, enabling, and reinforcing factors impacting genetic counseling/testing among ovarian cancer patients guided by Green and Kreuter’s PRECEDE-PROCEED model. METHODS: Gynecologic oncology providers (N=4), genetic couns
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ae88dddf208ea19fee06af2ccd40610
https://europepmc.org/articles/PMC7981241/
https://europepmc.org/articles/PMC7981241/
Autor:
Roberto J Vargas, Rod Quilitz, Stacy Martin, Michelle Kuznicki, David Boulware, Emily Clair McClung, Sachin M. Apte, Sarah L. Todd, Sharon E. Robertson, Adrianne Mallen
Publikováno v:
Int J Gynecol Cancer
BackgroundGynecologic oncology surgery is associated with a wide variation in surgical site infection risk. The optimal method for infection prevention in this heterogeneous population remains uncertain.Study DesignA retrospective cohort study was pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c94ba0bdee24466dbdea5b18d4db9f3
https://europepmc.org/articles/PMC7868167/
https://europepmc.org/articles/PMC7868167/